Key | % Net Assets |
---|---|
GlaxoSmithKline | 7.0% |
BP | 5.6% |
BG | 5.2% |
BAE Systems | 4.9% |
Other | 77.3% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 7.0% |
BP | 5.6% |
BG | 5.2% |
BAE Systems | 4.9% |
BG | 4.5% |
Rentokil Initial | 4.4% |
AstraZeneca | 4.3% |
Imperial Tobacco | 4.1% |
Legal & General | 3.9% |
Roche | 3.4% |
No asset data available.
Date | 07-May-2024 |
---|---|
NAV | 530.13p |
Currency | GBP |
Change | 5.30p |
% | 1.01% |
YTD change | 43.34p |
YTD % | 8.90% |
Fund Inception | 12/06/1987 |
---|---|
Fund Manager | Ed Burke |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.66% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.10 |
You are here: research